Follow
Sreedurgalakshmi K
Sreedurgalakshmi K
Tvaster Genkalp Pvt. Ltd, Vellore Institute of Technology
Verified email at tvastergen.com
Title
Cited by
Cited by
Year
Aggregation of respiratory complex subunits marks the onset of proteotoxicity in proteasome inhibited cells
S Rawat, V Anusha, M Jha, K Sreedurgalakshmi, S Raychaudhuri
Journal of molecular biology 431 (5), 996-1015, 2019
152019
CRISPR-Cas deployment in non-small cell lung cancer for target screening, validations, and discoveries
K Sreedurgalakshmi, R Srikar, R Rajkumari
Cancer Gene Therapy 28 (6), 566-580, 2021
112021
Cetuximab–siRNA conjugate linked through cationized gelatin knocks down KRAS G12C mutation in NSCLC sensitizing the cells toward gefitinib
K Sreedurgalakshmi, R Srikar, K Harikrishnan, L Srinivasan, R Rajkumari
Technology in Cancer Research & Treatment 20, 15330338211041453, 2021
82021
Acylation process for preparation of N-substituted peptide
R Srikar, V Jatin, K Sreedurgalakshmi
US Patent 11,702,446, 2023
2023
Antibody-biomolecule conjugates linked through multifunctional macromolecule and uses thereof
R Srikar, V Jatin, K Sreedurgalakshmi
US Patent App. 16/981,095, 2022
2022
Proteostasis perturbation destabilizes respiratory complex assembly-intermediates via aggregation of subunits
S Rawat, V Anusha, M Jha, K Sreedurgalakshmi, A Ghosh, D Ganguly, ...
bioRxiv, 312793, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–6